Fig. 2From: A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resectionForest plot of OS outcomes in patients who received sorafenib therapy for HCC after resection. OS, overall survival; HCC, hepatocellular carcinomaBack to article page